[1] Alexander D J. An overview of the epidemiology of avian influenza[J]. Vaccine,2007,25(30):5637-5644.
[2] Song J, Liang C, Chen X. Transduction of avian cells with recombinant baculovirus [J]. Virol Methods,2006,135(2):157-162.
[3] Peiris J S, De Jong M D, Guan Y. Avian influenza virus (H5N1): a threat to human health[J]. Clinical Microbial Review,2007,20(2):243-267.
[4] 刘志刚,刘立峰,陈伦勇,等.禽流感新型疫苗研究进展[J].动物医学进展,2013,34(2):99-103.
[5] 张严予,综述,廖国阳.大流行流感疫苗的研究进展[J].中国生物制品学杂志,2011,24(5):618-620.
[6] Masato H, Gao P, Halfmann P, et al. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses[J]. Science,2003,293(5536):1840-1842.
[7] Steinhauer D A. Role of hemagglutinin cleavage for the Pathogenieity of infiuenzavirus[J]. Virology,1999,258(l):l-20.
[8] Nili H, Asasi K. Natural cases and an experimental study of H9N2 avian influenza in commercial broiler chickens of Iran[J]. Avian Pathology,2002,31(3):247-252
[9] Crawford J, Wilkinson B, Vosnesensky A, et al. Baculovirus derived hemoglobin in vaccines protect against lethal influenza infections by avian H5 and H7 subtypes [J]. Vaccine,1999,17(8):2265-2274.
[10] Yu Z, Jin M, Zhang R, et al. Development of a sepecific latex agglutination test based on a recombinant hemagguluinin protein to dectect antibodies to H5 avian influenza viruses[J]. Avian Disease,2006,50(2):264-268.
[11] 何宏轩,秦曦明,张强哲,等.H9N2亚型禽流感病毒HA基因的克隆及其DNA疫苗的动物免疫试验[J].生物化学与生物物理进展,2004,31(2):62-64.
[12] Zhu F, Hua W, Fang H, et al. A novel influenza (H1N1) vaccine in various age groups[J]. Science,2009,25(361):2414-2423.
[13] Ha Y, Steven D J, Skehel J J, et al. H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes[J]. The EMBO journal,2002(21):865-875.
[14] Beigel J H, Farrar J, Han A M , et al. Avian influenza A (H5N1) infection in humans[J]. The New England journal of medicine,2005,353(13):1374-1377.
[15] Ranasinghe C, Medveczy J C, Woltring D, et al. Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1[J]. Vaccine,2006,24(31):5881-5895.
[16] Fouchier R A M, Hartwig N G, Bestebroer T M, et al. A previously undescribed coronavirus associated with respiratory diseased in humans[J]. Proceedings of the National Academy of Sciences of the United States of America,2004,101(16):6212-6216.
[17] 金元昌,李景鹏,张龙,等.禽流感病毒分子生物学研究进展[J].动物医学进展,2003,24(1):12-15.
[18] Li Z, Liu Z H, Ma C, et al. Identification of amino acids in highly pathogenic avian influenza H5N1 virus hemagglutinin that determine avian influenza species specificity[J]. Archives of Virology,2011,156(10):1803-1812.
[19] 唐秀英,付朝阳,冯菊艳.H9亚型禽流感的流行与防制[J].预防兽医学进展,2000,2(4):1-3.
[20] James S, Ola B, Terrence M T, et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus[J]. Science,2006,312(5772):404-410.
[21] Wang KY, Kathleen M H, Karl A, et al. Expression and purification of an influenza hemagglutinin: one step closer to a recombinant protein-based influenza vaccine[J]. Vaccine,2006,24(12):2176-2185.
[22] Li C J, Yu K, Tian Q, et al. Evolution of H9N2 influenza viruses from domestic poultry in Mainland China[J]. Virology,2005,340(1):70-83.
|